Literature DB >> 20563709

PDK1: the major transducer of PI 3-kinase actions.

José Ramón Bayascas1.   

Abstract

Most of the cellular responses to phosphatidylinositol 3-kinase activation and phosphatidylinositol 3,4,5-trisphosphate production are mediated by the activation of a group of AGC kinases comprising PKB, S6K, RSK, SGK and PKC isoforms, which play essential roles in regulating physiological processes related to cell growth, proliferation, survival and metabolism. All these growth-factor-stimulated AGC kinases possess a common upstream activator, namely PDK1, a master kinase, which, being constitutively active, is still able to phosphorylate and activate its AGC substrates in response to rises in the levels of the PtdIns(3,4,5)P(3) second messenger. In this chapter, the biochemical, structural and genetic data on the mechanism of action and physiological roles of PDK1 are reviewed, and its potential as a pharmaceutical target for the design of drugs therapeutically beneficial to treat human disease such us diabetes and cancer is discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20563709     DOI: 10.1007/82_2010_43

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  48 in total

Review 1.  AGC kinases in plant development and defense.

Authors:  Heribert Hirt; Ana V Garcia; Ralf Oelmüller
Journal:  Plant Signal Behav       Date:  2011-07

2.  Activated α2-macroglobulin binding to human prostate cancer cells triggers insulin-like responses.

Authors:  Uma Kant Misra; Salvatore Vincent Pizzo
Journal:  J Biol Chem       Date:  2015-02-26       Impact factor: 5.157

3.  Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer.

Authors:  Chandan Rana; Honit Piplani; Vivek Vaish; Bimla Nehru; S N Sanyal
Journal:  Mol Cell Biochem       Date:  2015-02-03       Impact factor: 3.396

4.  Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.

Authors:  Lihong Han; Guoxiu Zhang; Nali Zhang; Haiyan Li; Yanyan Liu; Aiguo Fu; Youguang Zheng
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

5.  Diversity, classification and function of the plant protein kinase superfamily.

Authors:  Melissa D Lehti-Shiu; Shin-Han Shiu
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-19       Impact factor: 6.237

6.  The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts.

Authors:  Joanna Zabkiewicz; Lorna Pearn; Robert K Hills; Rhys G Morgan; Alex Tonks; Alan K Burnett; Richard L Darley
Journal:  Haematologica       Date:  2013-12-13       Impact factor: 9.941

7.  Discovery of SBF1 as an allosteric inhibitor targeting the PIF-pocket of 3-phosphoinositide-dependent protein kinase-1.

Authors:  Wei Liu; Pengfei Li; Ye Mei
Journal:  J Mol Model       Date:  2019-06-13       Impact factor: 1.810

8.  Interaction of PDK1 with phosphoinositides is essential for neuronal differentiation but dispensable for neuronal survival.

Authors:  Tinatin Zurashvili; Lluís Cordón-Barris; Gerard Ruiz-Babot; Xiangyu Zhou; Jose M Lizcano; Nestor Gómez; Lydia Giménez-Llort; Jose R Bayascas
Journal:  Mol Cell Biol       Date:  2012-12-28       Impact factor: 4.272

9.  Fine-tuning the intensity of the PKB/Akt signal enables diverse physiological responses.

Authors:  Xiangyu Zhou; Lluis Cordon-Barris; Tinatin Zurashvili; Jose Ramon Bayascas
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  PDK1 inhibitors.

Authors:  Elisa Barile; Surya K De; Maurizio Pellecchia
Journal:  Pharm Pat Anal       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.